AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. AiCure delivers patient insights to improve clinical trials. As the only company to provide a holistic view of the patient, AiCure directly engages patients via smartphones to deliver meaningful, high-quality data around patient behavior to sponsors and sites. These insights from AiCure’s proprietary AI platform empower sites to better support patients and sponsors to implement the right trial for the right patient, helping drive greater understanding of drug efficacy, accelerate timelines, and reduce trial costs and variability. AiCure has more than 75 issued patents and works with global clients in over 45 countries.
AiCure improves predictability of study timelines, reduces costs and accelerates timelines through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing. Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors.